Maxipime Lawsuits
May 14th, 2008 • Filed Under: Lawsuits • One Comment
Maxipime is an injectable antibiotic which is used for treatment of serious infections, such as pneumonia. Recent studies have raised concerns about an increased risk of death found among individuals treated with the antibiotic.
STATUS OF MAXIPIME LAWSUITS: The potential for legal claims are being reviewed and evaluated on behalf of individuals who have died while being treated with the antibiotic.
OVERVIEW: Maxipime (cefepime) is a beta-lactam antibiotic injection which is approved for treatment of a variety of serious infections, including:
- Pneumonia
- Empiric therapy for febrile neutropenic patients
- Urinary Tract Infections (UTI) including pyelonephritis
- Skin Infections
- Intra-Abdominal Infections
MAXIPIME DEATH SIDE EFFECTS: A 2007 meta-analysis published in the Lancet Infectious Diseases found that the death rate among those using cefepime (Maxipime) was higher than what was associated with other similar antibiotics. The study included data from 57 different clinical trials, comparing results from those treated with Maxipime injection to those treated with another beta-lactam antibiotic, either alone or with the addition of a non-beta-lactam antibiotic.
On November 14, 2007, the FDA issued an “early communication” regarding the possible risk of death associated with Maxipime and indicated that they would be reviewing safety data before reaching any conclusions about the need for additional warnings or regulatory actions.
On May 14, 2008, an update was issued by the FDA, since they had not completed their review of the Maxipime side effects within four months, as they had originally anticipated. They indicated that their review is ongoing as they still have not received and reviewed all of the study data they have requested.
Review a potential Maxipime Lawsuit with lawyers who are evaluating the possibility for claims.
While the FDA review of safety data, lawyers are evaluating the potential for Maxipime lawsuits on behalf of individuals who died while being treated with the antibiotic. Submit information about a potential case to have it reviewed and evaluated. If it appears that compensation may be available, you may be contacted by a Maxipime attorney.
Pingback by FDA is Continuing to Review Safety Concerns About Maxipime (cefepime) Death Risk — AboutLawsuits.com on 14 May 2008:
[...] an early communication issued last November about concerns that an injectable antibiotic known as Maxipime (cefepime), may increase the risk of death when compared to similar drugs. Although the FDA originally [...]